Radiotherapy/chemotherapy/hormone Treatment May Prevent Breast Cancer Relapses
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Radiotherapy/chemotherapy/hormone Treatment May Prevent Breast Cancer Relapses

BRUSSELS, BELGIUM -- September 27, 2000 -- New findings show that adjuvant treatments prevent late relapses in breast cancer patients.

Breast cancer is an unusual disease because it can come back 10 or 15 years later. The new findings show that a lot of these late recurrences can be prevented by adjuvant treatment with radiotherapy, chemotherapy and, in particular, the hormone treatment tamoxifen.

"This is the first time we've had good evidence on the effects of treatment on 15 year survival", said Sir Richard Peto, Professor of Medical Statistics at the University of Oxford, UK. He told the 2nd European Breast Cancer Conference, Wednesday, 27 September: "These results, from a worldwide overview of 300 randomised trials, that included around 200 000 patients, are a lot better than we expected. It seems that we can at last talk about real cure", he said.

"The best evidence on the extent to which better treatment is saving lives is from the UK, where tamoxifen was widely used from the 1980s, and where deaths from breast cancer in middle-aged women have fallen by 30 percent over the past decade. It seems as though several other European countries are now beginning to follow in the same direction."

The next worldwide overview, in five years time, will show whether these survival gains are still being maintained.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities